Play Some Defense
Usually, when the market is doing well, stocks aren’t affected much by the news of the day. That’s not to say individual stocks don’t get pushed around, but for the market as a whole, worrisome headline news usually goes the way water...
Read More
This week is a still familiar story in the portfolio, with defensive stocks thriving and moving still higher.
Read More
Four stocks in our portfolios reported earnings this week.
Read More
The market has undergone a radical personality transformation since I released the July issue last week. I’m not hitting the panic button, yet. But it is certainly a situation I will closely monitor.
Read More
THE BIG IDEA
Back in the late 1800s if you called a company for information you were routed through a telephone exchange and were able to speak with a person that could help.
The last switchboard operator for a hand-crank phone, Susan Glines, walked away her...
Read More
Passing T-Storms—or Something More?
On this page of the last issue, we wrote “we think the near-term is a toss-up, at least when it comes to individual growth stocks— earnings season is always tricky, and let’s face it, many leaders have had great runs the...
Read More
Crista is changing the rating on two stocks and retiring another.
Read More
The Dog Days of Summer
We are in the dog days of summer, the hottest, most sultry days of the year. The expression “dog days” is an old one. In fact, it’s really old. The Romans used it.
It’s one of those expressions that everyone but...
Read More
Crista reports good earnings announcements in five portfolio stocks.
Read More
Thus far, the 11 portfolio companies that delivered second-quarter results have all met or exceeded Wall Street’s consensus earnings estimates.
Read More
It’s the middle of the summer swoon. But there’s a lot going on in the market, namely earnings. Overall, this earnings season is shaping up to be positive but uninspired.
Read More
Today’s news: One stock is now Retired from the Growth & Income Portfolio; and one stock joins the Buy Low Opportunities Portfolio as a Strong Buy.
Read More
Three of our portfolio stocks reported second-quarter (2Q) results. Here's what you need to know.
Read More
Mostly Sunny—with Possible T-Storms Along the Way
Ever since January 9, when the 2-to-1 Blastoff Indicator gave a rare buy signal just two weeks after the market’s major bottom, our greatest conviction has been that the overall market had likely entered a new bull that...
Read More
Things look pretty darn good. The S&P 500 has broken the 3000 level for the first time ever and is within a whisker of its all-time high. The index is up over 9% since the beginning of June and 20% so far in 2019.
Read More
One of our portfolio stocks reported strong second-quarter (2Q) results this morning, benefiting from higher fares and fuller planes.
Read More
The market is at new all-time highs. If there’s more bad news, it could go a lot higher. The biggest risk to the market right now is stronger-than-expected second-quarter GDP growth.
Read More
The Odds Still Favor Higher Prices Ahead
It was a solid first half of 2019 for most major indexes and growth stocks. Despite a few knocks upside the head last week, our Model Portfolio finished June up nearly 22% on the year. In fact, the...
Read More
The S&P 500 is at new all time highs as I write this. We have a market that wants to go higher, but it just keeps getting interrupted with negative headlines. It seems like we can’t get through a week without bad trade or...
Read More
THE BIG IDEA
A few years back the Institute of Medicine (IOM) published a report with an astounding conclusion:
Most people will experience at least one diagnostic error in their lifetime, sometimes with devastating consequences.
That’s not cool.
Diagnostic accuracy of some conditions is staggeringly bad. For the...
Read More